Dear Colleagues:

Within pharma companies, medical departments have steadily risen to prominence. As well as having a grip on key scientific, medical and compliance issues, medical staff must engage more deeply with customers while cultivating a new appreciation of the company’s commercial and strategic challenges.

In all these endeavors, medical affairs must work with new types of data being generated from a multiplicity of sources inside and outside the organization.

Download your free white paper on The digital transformation of medical here.

By reading this white paper, you will learn:

  • How medical affairs can best harness the potential of digital: for optimized intelligence gathering, engagement and reach, agile innovation and the gaining of valuable new insights
  • Proven strategies for tackling challenges associated with digital transformation: including working with regulators, getting the medical education balance right, overcoming customer technophobia, pharma’s skills deficits, and more.
  • How you can roll out digital medical tools at scale: pioneers share their lessons learned, including tackling easy digital implementations first, establishing a strong business case, transcending silos and retaining strategic customer focus.

Contributors include:

  • Juan Ovalle, Chief Medical Officer-Global Medical and Clinical, Upjohn Division, Pfizer
  • Ameet Nathwani, Chief Medical Officer and Chief Digital Officer, Sanofi
  • Christopher Keenan, Head of Medical Customer Engagement, BMS
  • Nina Belly, Global Medical Affairs Information Transformation Lead, Merck
  • Daniel Ruzicka, Executive Director Medical Affairs, MSD KK

“Nobody has the greater potential to innovate” – Christopher Keenan, Head of Medical Customer Engagement, BMS

Take full advantage of medical’s digital potential – download the free white paper here.

I hope their insights will be beneficial to you. Thanks to James Mackintosh from eyeforpharma for sharing this with us. If you would like more information, please contact him at

Best regards,

Lucy Muñiz MD
Editor The Pharmaceutical Marketing Group